Literature DB >> 9800746

Steroids and Churg-Strauss syndrome.

A Churg, J Churg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9800746     DOI： 10.1016/S0140-6736(05)79511-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Corneal melt secondary to eosinophilic granulomatosis with polyangiitis.

Authors:  Evelyn Fennelly; Emily Greenan; Conor C Murphy
Journal:  BMJ Case Rep       Date:  2019-06-21

Review 3.  Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

Authors:  Richard B R Muijsers; Stuart Noble
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Pharmacokinetic profile of zafirlukast.

Authors:  P N Richard Dekhuijzen; Peter P Koopmans
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

6.  Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

Authors:  M E Wechsler; R Pauwels; J M Drazen
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

7.  Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.

Authors:  Beverley R Twaites; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Benefit-risk assessment of antileukotrienes in the management of asthma.

Authors:  Luis García-Marcos; Antje Schuster; Eduardo G Pérez-Yarza
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Acute fulminant necrotizing eosinophilic myocarditis: early diagnosis and treatment.

Authors:  Paul David Callan; Aigul Baltabaeva; Mohammed Kamal; Joyce Wong; Rebecca Lane; Jan Lukas Robertus; Nicholas R Banner
Journal:  ESC Heart Fail       Date:  2017-07-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.